Digital Respiratory Devices Market
Digital Respiratory Devices Market Size, Share & Forecast Analysis, By Product (Smart Inhalers & Nebulizers, Sensors & Apps), By Indication (Asthma, COPD), By Distribution Channel (Hospital, Retail & Online Pharmacies), By End-Use & Region - Global Market Insights 2022-2032
Analysis of Digital Respiratory Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Digital Respiratory Devices Market Outlook (2022-2032)
The global digital respiratory devices market was valued at US$ 43 Billion in 2022 and is expected to expand at a CAGR of 25% from 2022 to 2032. The increased frequency of respiratory disorders has pushed for advancements in the production of breathing equipment.
Asthmatic and chronic obstructive pulmonary disease (COPD) patients have sought more accuracy in medicine administration, leading to a rise in the use of digital respiratory devices. Government’s reimbursement policies that favour digital respiratory devices production and sales.
Report Attributes |
Details |
|---|---|
|
Market Size (2022) |
US$ 43 Billion |
|
Projected Market Value (2032) |
US$ 400 Billion |
|
Global Market Growth Rate (2022-2032) |
25% CAGR |
|
Forecast Period |
2022-2032 |
|
Historical Data Available For |
2017-2021 |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis of Digital Respiratory Devices (2017-2021) in Comparison to Market Forecasts (2022-2032)
Chronic obstructive pulmonary disease (COPD) is a serious health problem and one of the top causes of mortality worldwide, according to the World Health Organization (WHO). Medical devices that are technologically advanced and effective medications have become critical in the treatment of COPD and other respiratory illnesses.
For example, in 2016, the United Nations established the Sustainable Development Goals (SDG) to enhance global living standards. Similarly, the Forum of International Respiratory Societies (FIRS) was established to address the growing burden of respiratory diseases. These efforts have a significant impact on increasing demand for digital respiratory devices.
Over the recent decade, several novel medications for the treatment of COPD and other respiratory illnesses such as asthma have been introduced. With more items in the pipeline, the digital respiratory devices market will have more room for growth, especially because demand for respiratory devices has increased due to the COVID-19 pandemic.
The pandemic issue has resulted in accelerated medicine approval and product launch, which is the most popular among pharmaceutical producers. The COVID-19 has resulted in manufacturing relationships between healthcare and non-healthcare companies. To satisfy rising demand, manufacturers are ramping up production of breathing equipment. These developments are indicative of positive progress. The global respiratory devices market is expected to develop at a 25% CAGR through 2032, according to Fact.MR.
What is Shaping Digital Respiratory Devices Market Growth Potential?
Rising Inclination towards Combination Medicines anticipated driving the Global Market
The usage of combination treatments for COPD and asthma therapy has steadily increased. Patients choose combination treatments due to benefits such as higher effectiveness, greater dependability in difficult patients, and advantageous therapy reimbursement policies.
A crucial reason for digital respiratory device makers is the growing inclination for combination medicines such as triple combination therapy. Combination therapy is regarded as a dependable source of treatment for people suffering from complicated respiratory illnesses. Furthermore, excellent reimbursement schemes have encouraged the use of these medicines.
Expanding Frequency of Respiratory Diseases to Propel Market Growth
As stated by the World Health Organization (WHO), COPD will be the third greatest cause of mortality worldwide by 2025. The expanding frequency of respiratory diseases, as well as the growing demand for efficient treatment, has resulted in increased development potential. The digital respiratory devices market is likely to develop significantly in the next years as attractive reimbursement policies are implemented.
Upgrades in the government healthcare system, as well as an increasing emphasis on improved treatment with more accessibility, will offer a profitable development opportunity. For example, the Affordable Care Act is being implemented to assist roughly 40 million uninsured Americans in gaining access to healthcare services.
Similarly, individuals in England have access to free health care. Every citizen of the nation has access to preventative medicine, primary care, and hospital treatments through the National Health Service (NHS). For example, significant reforms were implemented in the NHS in 2018 that will empower social care leaders to explicitly design treatment for individual patients, which will be increasingly made available outside of hospitals. These initiatives aimed at making healthcare more accessible will create a favourable climate for the marketing of digital respiratory devices.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are Some Factors Restraining Market Growth?
Lack of Reimbursement for Numerous Diagnostic Tests Driving Market
To some degree, market expansion has been impeded by a lack of knowledge, which has resulted in a significant underdiagnosed and undertreated population, as well as the adverse effects of particular digital respiratory devices on newborns.
Furthermore, the diagnostic sector as a whole and respiratory care diagnostic in particular, is currently confronted with the difficulty of a lack of reimbursement for numerous diagnostic tests.
What Prospects Define Digital Respiratory Devices Market Potential on a Regional Basis?
In recent years, the North American market has held a significant proportion of the worldwide digital respiratory devices industry. The region's prominence is ascribed to the existence of well-developed healthcare infrastructure, expanding population awareness, and continual technological improvements.
Because of the rising patient pool impacted by respiratory disorders, the area is expected to continue to dominate in the future years. Rising COPD incidence is expected to drive demand for respiratory devices in the region. On the other hand, the use of digital respiratory devices in hospitals and healthcare facilities across the UK is predicted to increase significantly.
The market for digital respiratory devices is expected to increase as a consequence of initiatives by different government organisations such as the European Academy of Allergy & Clinical Immunology to raise awareness about COPD and other respiratory disorders such as asthma. According to PMR, Europe is the second-largest market, a position it is anticipated to maintain during the forecast period.
Country-wise Insights
Why are Suppliers of Digital Respiratory Devices investing in the U.S.?
Presence of Major Firms in the U.S to Drive the Market Growth
North America holds the greatest proportion of the market under consideration. This is mostly due to the rising prevalence of respiratory disorders. Furthermore, the presence of major firms in the US is one of the primary reasons driving the growth of the US digital respiratory devices market.
According to the Asthma and Allergy Foundation of America's April 2021 data, about 20 million individuals aged 18 and up in the United States have asthma. As a result, the frequency of such conditions in the country implies a steady need for digital respiratory devices, which contributes to the growth of the market analysed in the United States. ?The outbreak of COVID-19 has boosted market expansion even further. The US government is launching a number of strategic projects. In the COVID-19 pandemic, for example, Philips and the US government worked in April 2020 to enhance hospital ventilator output.
Similarly, the office of the Assistant Secretary for Preparedness and Response (ASPR) added numerous additional mechanical ventilator types to the stockpile in 2020, according to the 2021 American Association for Respiratory Care. As a result of the foregoing considerations, the United States is likely to dominate the worldwide market for digital respiratory devices.
How Will the Chinese Digital Respiratory Devices Market Evolve?
Rising Incidences of COPD and Asthma in China to boost the Regional Market Growth
During the projection period, Asia Pacific is expected to grow at a significant. This increase can be ascribed to rising incidences of COPD and asthma in China. COPD is the primary cause of impairment in China, and it is an increasing public health problem.
AstraZeneca's Bevespi Aerosphere was approved in China in May 2020 as a maintenance medication for the treatment of COPD symptoms such as chronic bronchitis and emphysema.
Category-wise Insights
By Indication, which Segment is Driving Market Growth?
COPD is expected to grow at a significant rate
In 2021, the COPD category topped the market with a significant profit share in the market. COPD affects 200 million individuals globally. Moreover, respiratory disorders account for little and over 8% of all chronic diseases worldwide. As stated by the World Health Organization (2020), COPD will overtake ischemic heart disease and HIV/AIDS as the fourth-leading causes of mortality by 2030.
Furthermore, individuals continuing to smoke and living longer lives are all leading to the huge growth of COPD; these changes are especially important in developing countries. Asthma affects around 300 million individuals worldwide, and the prevalence of the ailment is growing by 50% every ten years.
In addition to that, asthma affects about 25 million individuals in the United States, accounting for 10% of the population in North America. Furthermore, an increase in severe asthma, insufficient illness management, and poverty are all consequences of the rising number of asthma hospitalizations, particularly among young children. As a result, there is a growing need for digital respiratory devices.
Which End Use Shows Higher Implementation in Digital Respiratory Devices Industy?
Demand from the Hospitals to Gain the Most Traction
In 2022, hospitals are anticipated to hold the highest revenue share of the digital respiratory devices market. The hospital category is expected to expand significantly in the coming years as a result of expanding public-private partnerships, rapid improvements in healthcare infrastructure, and increased access to healthcare services. Hospitals, homecare settings, and other settings make up the market. Due to the cost advantages of home care equipment and services over hospital visits, the homecare settings category is expected to grow at the fastest over the projected period.
Moreover, due to the rising costs of the healthcare business, many people with chronic respiratory diseases opt to get care at home. Furthermore, the increasing prevalence of chronic conditions such as COPD and asthma throughout the world is the primary driver of the homecare business.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Regional developments through mergers and alliances, as well as product releases, are some of the primary methods employed by market participants.
Recent Developments :
- In September 2021, Adherium Limited, a market leader in respiratory eHealth, remote monitoring, and data management, announced that the FDA's 510(k) approval has allowed it to begin selling its first, next-generation Hailie Sensor, which includes physiological measures for tracking the use of asthma and COPD medications.
- In November 2019, Propeller Health expanded their pharmacy refill app to cover CVS, Rite-Aid, Kroger, and Walmart pharmacies.
- In January 2019, Propeller Health also launched My Drugstore, an in-app service in collaboration with Walgreens that allows clients to manage their medication refills for COPD and asthma and locate a nearby pharmacy.
Key Segments in Digital Respiratory Devices Industry Research
-
By Product :
- Smart Inhalers & Nebulizers
- Sensors & Apps
-
By Indication :
- Asthma
- COPD
- Other Diseases
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
By End Use :
- Hospitals
- Homecare Settings
- Other settings
-
By Region :
- North America
- Europe
- East Asia
- South Asia
- Oceania
- Latin America
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2022-2032 5.3.1. Smart inhalers & Nebulizers 5.3.2. Sensors & Apps 5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032 6.3.1. Asthma 6.3.2. COPD 6.3.3. Other Diseases 6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021 6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-Use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End-Use , 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-Use , 2022-2032 7.3.1. Hospitals 7.3.2. Homecare Settings 7.3.3. Other settings 7.4. Y-o-Y Growth Trend Analysis By End-Use , 2017-2021 7.5. Absolute $ Opportunity Analysis By End-Use , 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032 8.3.1. Hospital Pharmacies 8.3.2. Retail Pharmacies 8.3.3. Online Pharmacies 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Product 10.2.3. By Indication 10.2.4. By End-Use 10.2.5. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Indication 10.3.4. By End-Use 10.3.5. By Distribution Channel 10.4. Key Takeaways 11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product 11.2.3. By Indication 11.2.4. By End-Use 11.2.5. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Indication 11.3.4. By End-Use 11.3.5. By Distribution Channel 11.4. Key Takeaways 12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Product 12.2.3. By Indication 12.2.4. By End-Use 12.2.5. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Indication 12.3.4. By End-Use 12.3.5. By Distribution Channel 12.4. Key Takeaways 13. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Product 13.2.3. By Indication 13.2.4. By End-Use 13.2.5. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Indication 13.3.4. By End-Use 13.3.5. By Distribution Channel 13.4. Key Takeaways 14. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Indication 14.2.4. By End-Use 14.2.5. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Indication 14.3.4. By End-Use 14.3.5. By Distribution Channel 14.4. Key Takeaways 15. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Product 15.2.3. By Indication 15.2.4. By End-Use 15.2.5. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End-Use 15.3.5. By Distribution Channel 15.4. Key Takeaways 16. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Product 16.2.3. By Indication 16.2.4. By End-Use 16.2.5. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product 16.3.3. By Indication 16.3.4. By End-Use 16.3.5. By Distribution Channel 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. U.S. 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2021 17.1.2.1. By Product 17.1.2.2. By Indication 17.1.2.3. By End-Use 17.1.2.4. By Distribution Channel 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2021 17.2.2.1. By Product 17.2.2.2. By Indication 17.2.2.3. By End-Use 17.2.2.4. By Distribution Channel 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2021 17.3.2.1. By Product 17.3.2.2. By Indication 17.3.2.3. By End-Use 17.3.2.4. By Distribution Channel 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2021 17.4.2.1. By Product 17.4.2.2. By Indication 17.4.2.3. By End-Use 17.4.2.4. By Distribution Channel 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2021 17.5.2.1. By Product 17.5.2.2. By Indication 17.5.2.3. By End-Use 17.5.2.4. By Distribution Channel 17.6. U.K. 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2021 17.6.2.1. By Product 17.6.2.2. By Indication 17.6.2.3. By End-Use 17.6.2.4. By Distribution Channel 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2021 17.7.2.1. By Product 17.7.2.2. By Indication 17.7.2.3. By End-Use 17.7.2.4. By Distribution Channel 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2021 17.8.2.1. By Product 17.8.2.2. By Indication 17.8.2.3. By End-Use 17.8.2.4. By Distribution Channel 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2021 17.9.2.1. By Product 17.9.2.2. By Indication 17.9.2.3. By End-Use 17.9.2.4. By Distribution Channel 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2021 17.10.2.1. By Product 17.10.2.2. By Indication 17.10.2.3. By End-Use 17.10.2.4. By Distribution Channel 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2021 17.11.2.1. By Product 17.11.2.2. By Indication 17.11.2.3. By End-Use 17.11.2.4. By Distribution Channel 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2021 17.12.2.1. By Product 17.12.2.2. By Indication 17.12.2.3. By End-Use 17.12.2.4. By Distribution Channel 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2021 17.13.2.1. By Product 17.13.2.2. By Indication 17.13.2.3. By End-Use 17.13.2.4. By Distribution Channel 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2021 17.14.2.1. By Product 17.14.2.2. By Indication 17.14.2.3. By End-Use 17.14.2.4. By Distribution Channel 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2021 17.15.2.1. By Product 17.15.2.2. By Indication 17.15.2.3. By End-Use 17.15.2.4. By Distribution Channel 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2021 17.16.2.1. By Product 17.16.2.2. By Indication 17.16.2.3. By End-Use 17.16.2.4. By Distribution Channel 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2021 17.17.2.1. By Product 17.17.2.2. By Indication 17.17.2.3. By End-Use 17.17.2.4. By Distribution Channel 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2021 17.18.2.1. By Product 17.18.2.2. By Indication 17.18.2.3. By End-Use 17.18.2.4. By Distribution Channel 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2021 17.19.2.1. By Product 17.19.2.2. By Indication 17.19.2.3. By End-Use 17.19.2.4. By Distribution Channel 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2021 17.20.2.1. By Product 17.20.2.2. By Indication 17.20.2.3. By End-Use 17.20.2.4. By Distribution Channel 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2021 17.21.2.1. By Product 17.21.2.2. By Indication 17.21.2.3. By End-Use 17.21.2.4. By Distribution Channel 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product 18.3.3. By Indication 18.3.4. By End-Use 18.3.5. By Distribution Channel 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. COHERO Health Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Cognita Labs 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Adherium Limited 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Amiko Digital Health Limited 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Teva Pharmaceuticals Industries Ltd. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Propeller Health 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Novartis AG 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Pneuma Respiratory Inc. 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. 3M Health Care Limited 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. AireHealth, Inc. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 03: Global Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 04: Global Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 05: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 06: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 07: North America Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 08: North America Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 09: North America Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 10: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 12: Latin America Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 13: Latin America Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 14: Latin America Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 15: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: Europe Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 18: Europe Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 19: Europe Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 20: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 21: South Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: South Asia Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 23: South Asia Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 24: South Asia Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 25: South Asia Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 26: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 27: East Asia Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 28: East Asia Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 29: East Asia Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 30: East Asia Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 31: Oceania Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 32: Oceania Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 33: Oceania Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 34: Oceania Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 35: Oceania Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
Table 36: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 37: MEA Market Value (US$ Mn) Forecast by Product, 2017-2032
Table 38: MEA Market Value (US$ Mn) Forecast by Indication, 2017-2032
Table 39: MEA Market Value (US$ Mn) Forecast by End-Use , 2017-2032
Table 40: MEA Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by Product, 2022-2032
Figure 02: Global Market Value (US$ Mn) by Indication, 2022-2032
Figure 03: Global Market Value (US$ Mn) by End-Use , 2022-2032
Figure 04: Global Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 05: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 06: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 07: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 08: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 09: Global Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 12: Global Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 13: Global Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 14: Global Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 15: Global Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 16: Global Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 17: Global Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 18: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 21: Global Market Attractiveness by Product, 2022-2032
Figure 22: Global Market Attractiveness by Indication, 2022-2032
Figure 23: Global Market Attractiveness by End-Use , 2022-2032
Figure 24: Global Market Attractiveness by Distribution Channel, 2022-2032
Figure 25: Global Market Attractiveness by Region, 2022-2032
Figure 26: North America Market Value (US$ Mn) by Product, 2022-2032
Figure 27: North America Market Value (US$ Mn) by Indication, 2022-2032
Figure 28: North America Market Value (US$ Mn) by End-Use , 2022-2032
Figure 29: North America Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 30: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 34: North America Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 37: North America Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 38: North America Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 39: North America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 40: North America Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 41: North America Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 42: North America Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 43: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 46: North America Market Attractiveness by Product, 2022-2032
Figure 47: North America Market Attractiveness by Indication, 2022-2032
Figure 48: North America Market Attractiveness by End-Use , 2022-2032
Figure 49: North America Market Attractiveness by Distribution Channel, 2022-2032
Figure 50: North America Market Attractiveness by Country, 2022-2032
Figure 51: Latin America Market Value (US$ Mn) by Product, 2022-2032
Figure 52: Latin America Market Value (US$ Mn) by Indication, 2022-2032
Figure 53: Latin America Market Value (US$ Mn) by End-Use , 2022-2032
Figure 54: Latin America Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 55: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 59: Latin America Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 62: Latin America Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 65: Latin America Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 66: Latin America Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 68: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 71: Latin America Market Attractiveness by Product, 2022-2032
Figure 72: Latin America Market Attractiveness by Indication, 2022-2032
Figure 73: Latin America Market Attractiveness by End-Use , 2022-2032
Figure 74: Latin America Market Attractiveness by Distribution Channel, 2022-2032
Figure 75: Latin America Market Attractiveness by Country, 2022-2032
Figure 76: Europe Market Value (US$ Mn) by Product, 2022-2032
Figure 77: Europe Market Value (US$ Mn) by Indication, 2022-2032
Figure 78: Europe Market Value (US$ Mn) by End-Use , 2022-2032
Figure 79: Europe Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 80: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 84: Europe Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 85: Europe Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 87: Europe Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 88: Europe Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 90: Europe Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 91: Europe Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 92: Europe Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 93: Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 94: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 95: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 96: Europe Market Attractiveness by Product, 2022-2032
Figure 97: Europe Market Attractiveness by Indication, 2022-2032
Figure 98: Europe Market Attractiveness by End-Use , 2022-2032
Figure 99: Europe Market Attractiveness by Distribution Channel, 2022-2032
Figure 100: Europe Market Attractiveness by Country, 2022-2032
Figure 101: South Asia Market Value (US$ Mn) by Product, 2022-2032
Figure 102: South Asia Market Value (US$ Mn) by Indication, 2022-2032
Figure 103: South Asia Market Value (US$ Mn) by End-Use , 2022-2032
Figure 104: South Asia Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 105: South Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 106: South Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 109: South Asia Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 110: South Asia Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 112: South Asia Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 113: South Asia Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 115: South Asia Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 116: South Asia Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 117: South Asia Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 118: South Asia Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 119: South Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 120: South Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 121: South Asia Market Attractiveness by Product, 2022-2032
Figure 122: South Asia Market Attractiveness by Indication, 2022-2032
Figure 123: South Asia Market Attractiveness by End-Use , 2022-2032
Figure 124: South Asia Market Attractiveness by Distribution Channel, 2022-2032
Figure 125: South Asia Market Attractiveness by Country, 2022-2032
Figure 126: East Asia Market Value (US$ Mn) by Product, 2022-2032
Figure 127: East Asia Market Value (US$ Mn) by Indication, 2022-2032
Figure 128: East Asia Market Value (US$ Mn) by End-Use , 2022-2032
Figure 129: East Asia Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 130: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 131: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 134: East Asia Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 137: East Asia Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 138: East Asia Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 140: East Asia Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 141: East Asia Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 142: East Asia Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 143: East Asia Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 144: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 145: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 146: East Asia Market Attractiveness by Product, 2022-2032
Figure 147: East Asia Market Attractiveness by Indication, 2022-2032
Figure 148: East Asia Market Attractiveness by End-Use , 2022-2032
Figure 149: East Asia Market Attractiveness by Distribution Channel, 2022-2032
Figure 150: East Asia Market Attractiveness by Country, 2022-2032
Figure 151: Oceania Market Value (US$ Mn) by Product, 2022-2032
Figure 152: Oceania Market Value (US$ Mn) by Indication, 2022-2032
Figure 153: Oceania Market Value (US$ Mn) by End-Use , 2022-2032
Figure 154: Oceania Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 155: Oceania Market Value (US$ Mn) by Country, 2022-2032
Figure 156: Oceania Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 159: Oceania Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 160: Oceania Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 162: Oceania Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 165: Oceania Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 166: Oceania Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 167: Oceania Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 168: Oceania Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 169: Oceania Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 170: Oceania Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 171: Oceania Market Attractiveness by Product, 2022-2032
Figure 172: Oceania Market Attractiveness by Indication, 2022-2032
Figure 173: Oceania Market Attractiveness by End-Use , 2022-2032
Figure 174: Oceania Market Attractiveness by Distribution Channel, 2022-2032
Figure 175: Oceania Market Attractiveness by Country, 2022-2032
Figure 176: MEA Market Value (US$ Mn) by Product, 2022-2032
Figure 177: MEA Market Value (US$ Mn) by Indication, 2022-2032
Figure 178: MEA Market Value (US$ Mn) by End-Use , 2022-2032
Figure 179: MEA Market Value (US$ Mn) by Distribution Channel, 2022-2032
Figure 180: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 181: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 184: MEA Market Value (US$ Mn) Analysis by Product, 2017-2032
Figure 185: MEA Market Value Share (%) and BPS Analysis by Product, 2022-2032
Figure 186: MEA Market Y-o-Y Growth (%) Projections by Product, 2022-2032
Figure 187: MEA Market Value (US$ Mn) Analysis by Indication, 2017-2032
Figure 188: MEA Market Value Share (%) and BPS Analysis by Indication, 2022-2032
Figure 189: MEA Market Y-o-Y Growth (%) Projections by Indication, 2022-2032
Figure 190: MEA Market Value (US$ Mn) Analysis by End-Use , 2017-2032
Figure 191: MEA Market Value Share (%) and BPS Analysis by End-Use , 2022-2032
Figure 192: MEA Market Y-o-Y Growth (%) Projections by End-Use , 2022-2032
Figure 193: MEA Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032
Figure 194: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032
Figure 195: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032
Figure 196: MEA Market Attractiveness by Product, 2022-2032
Figure 197: MEA Market Attractiveness by Indication, 2022-2032
Figure 198: MEA Market Attractiveness by End-Use , 2022-2032
Figure 199: MEA Market Attractiveness by Distribution Channel, 2022-2032
Figure 200: MEA Market Attractiveness by Country, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the global digital respiratory devices market?
The global digital respiratory devices market accounts for a revenue of US$ 43 Billion in 2022.
What is the expected digital respiratory devices market size for 2032?
The global market for digital respiratory devices is expected to reach US$ 400 Billion by 2032.
What is the digital respiratory devices market predicted growth rate?
Demand for digital respiratory devices from 2022 to 2032 is projected to expand at a stellar CAGR of 25%.
Which end use of digital respiratory devices market accounts for maximum share?
By 2032, the hospital segment is projected to hold a maximum share of 50% of the market.
Which prominent suppliers of digital respiratory devices are operating in the global marketplace?
Key suppliers of digital respiratory devices are Cohero Health Inc., Cognita labs, Adherium limited, Amiko digital health limited, Teva pharmaceuticals industries ltd., Propeller health, Novartis ag, Pneuma respiratory inc., 3m health care limited, Airehe
Digital Respiratory Devices Market